Two marketing partners are expected to launch clopidogrel (original product: Plavix/Iscover by Bristol-Myers Squibb/Sanofi-Aventis) in Germany. Applications for approval in additional European countries are in preparation.
Luzi von Bidder, chairman of the board of Schweizerhall Holding, said: “The approval of clopidogrel in Germany represents a milestone for the Schweizerhall Group. Clopidogrel, developed by Cimex, will be the first more cost-effective alternative of this drug in the German market.”